ARF1 and enterovirus infectious disease: Collectively, our results demonstrate that the inhibitory effect of BFA on enterovirus replication can be reversed by mutations that increase the interaction of the viral protein 2C with the active (GTP-bound) form of Arf1, which strongly suggests that the requirement for such interaction determines the sensitivity of enterovirus infection to BFA in the first place.